What is ABSI's current stock price?

ABSI (Absci Corporation) is currently trading at $5.10 with a market cap of $795.1M.

What sector is Absci Corporation in?

Absci Corporation (ABSI) operates in the Healthcare sector, specifically in the Biotechnology industry.

Is ABSI a good stock to buy?

Analysts have a Buy consensus on ABSI with a price target of $6.05. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

ABSI Absci Corporation

Healthcare

$5.10+0.20%ClosedMarket Cap: $795.1M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

4.54

P/S

433.07

EV/EBITDA

-6.85

DCF Value

$0.04

FCF Yield

-12.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

-1316.9%

Operating Margin

-7000.8%

Net Margin

-6450.8%

ROE

-63.6%

ROA

-60.6%

ROIC

-72.3%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$215.0K	$-29.6M	$—
Q4 null	$650.0K	$-29.6M	$—
FY null	$2.8M	$-115.2M	$—
Q3 null	$378.0K	$-28.7M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$6.05

Target (Median)

$6.05

Target Range

$4.10 - $8.00

2 Strong Buy6 Buy1 Hold0 Sell0 Strong Sell

Truist SecuritiesBuy

2026-05-08

NeedhamBuy

2026-03-30

HC Wainwright & Co.Buy

2025-12-18

NeedhamBuy

2025-12-12

Morgan StanleyOverweight

2025-08-18

Trading Activity

Insider Trades

View All

Pangalos Menelas Ndirector

BuyWed May 13

Busch Andreasofficer: Chief Innovation Officer

BuyMon Mar 16

Pangalos Menelas Ndirector

SellThu Mar 05

Pangalos Menelas Ndirector

SellThu Mar 05

Walker Shelby J.officer: Chief Legal Officer

SellWed Mar 04

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

2.38

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Peers